Unlocking the Economic Potential of the Biologics Sector

added blog Health

2026-01-13 15:22:51 -

The economic footprint of the biotechnology industry has expanded rapidly, with antibodies taking the lion's share of the value. This growth is driven by the consistent clinical success of monoclonal antibodies (mAbs) across a variety of medical specialties. From managing inflammatory bowel disease to preventing organ rejection in transplant recipients, the utility of these proteins is vast....

0 Comments 0 Shares 13 Views 0 Reviews